Preferred Label : spironolactone;

MeSH definition : A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827);

MeSH synonym : veroshpiron; verospirone; spirolactone;

CISMeF synonym : pharmacia brand of spironolactone; pharmacia spain brand of spironolactone; alphapharm brand of spironolactone; betapharm brand of spironolactone; wörwag brand of spironolactone; alpharma brand of spironolactone; dexo brand of spironolactone; ashbourne brand of spironolactone; roche brand of spironolactone; searle brand of spironolactone; pfizer brand of spironolactone; azupharma brand of spironolactone; merck dura brand of spironolactone; alter brand of spironolactone; mundogen brand of spironolactone; Mayoly-Spindler brand of spironolactone; jenapharm brand of spironolactone; novopharm brand of spironolactone; cardel brand of spironolactone; pharmafrid brand of spironolactone; ct-Arzneimittel brand of spironolactone; ct arzneimittel brand of spironolactone; generosan brand of spironolactone; hormosan brand of spironolactone;

MeSH hyponym : spirospare; espironolactona alter; jenaspiron; spironone; aquareduct; Novo-Spiroton; frumikal; espironolactona mundogen; aldactone A; SC-9420; duraspiron; verospiron; spiro von ct; spirolang; Spirono-Isis; practon; spirobeta; spirogamma; spiractin; flumach; aldactone; spiro L.U.T.; Spirono Isis; Novo Spiroton; NovoSpiroton; SC 9420; SC9420; Ct, Spiro Von; Von Ct, Spiro;

MeSH CAS label : Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, gamma-lactone, (7alpha,17alpha)-;

MeSH Related Number : 52-01-7 (Spironolactone);

Registry Number MeSH : 52-01-7;

Wikipedia link : https://en.wikipedia.org/wiki/Spironolactone;

Codes EINECS : 200-133-6;

Is substance : O;

UNII : 27O7W4T232;

InChIKey : LXMSZDCAJNLERA-ZHYRCANASA-N;

Details


Main resources

You can consult :

A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)

https://www.ema.europa.eu/en/medicines/human/EPAR/qaialdo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
spironolactone
spironolactone
spironolactone
diuretics
diuretics
edema
edema, cardiac
liver cirrhosis
ascites
nephrotic syndrome
hypertension
hyperaldosteronism
hyperaldosteronism
administration, oral
adult
aged
child
infant, newborn
infant
drug interactions
pregnancy
breast feeding
aldosterone antagonists
aldosterone antagonists
drug evaluation, preclinical

---
https://www.sudoc.fr/255477066
2021
France
dissertations, academic
review literature as topic
spironolactone
Systematics
alopecia
hair
spironolactone
Literature
Taxonomy
fall, nos
Systematic Review
Systematics
Systematics
hair of scalp
classification
hair
Systematic Review

---
http://www.has-sante.fr/portail/jcms/c_2617856/fr/aldactone
http://www.has-sante.fr/portail/jcms/c_1147525/aldactone
http://www.has-sante.fr/portail/jcms/c_459647/fr/aldactone
2016
false
France
French
treatment outcome
spironolactone
mineralocorticoid receptor antagonists
diuretics
administration, oral
insurance, health, reimbursement
-
spironolactone
ascites
tablets
child
adult
edema
heart failure
hypertension
hyperaldosteronism
myasthenia gravis
diuretics, potassium sparing
evaluation of the transparency committee

---
https://minerva-ebp.be/FR/Article/2035
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
hypertension
Blood pressure increased refractory
spironolactone
treatment outcome
chemotherapy, adjuvant

---
http://www.has-sante.fr/portail/jcms/c_2040111/fr/inspra
http://www.has-sante.fr/portail/jcms/c_1626105/fr/inspra
http://www.has-sante.fr/portail/jcms/c_973827/inspra
2015
false
France
French
heart failure
myocardial infarction
eplerenone
administration, oral
mineralocorticoid receptor antagonists
spironolactone
insurance, health, reimbursement
ventricular dysfunction, left
evaluation of the transparency committee
diuretics, potassium sparing
Eplerenone

---
Maintien du remboursement dans les mêmes conditions
http://www.has-sante.fr/portail/jcms/c_2031563/fr/aldactazine
http://www.has-sante.fr/portail/jcms/c_847979/aldactazine
2015
false
France
French
Hepatic induced oedema
evaluation of the transparency committee
drug combinations
althiazide
spironolactone
mineralocorticoid receptor antagonists
diuretics
antihypertensive agents
altizide and potassium-sparing agents
sulfonamides
administration, oral
insurance, health, reimbursement
hypertension
edema
spironolactone, althiazide drug combination
benzothiadiazines
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/jcms/c_1364581/spiroctan
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-03/spiroctan_ri_avis1_ct12678_2013-03-07_16-32-12_751.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400746
2013
France
French
spironolactone
diuretics
mineralocorticoid receptor antagonists
administration, oral
insurance, health, reimbursement
treatment outcome
spironolactone
hyperaldosteronism
hypertension
edema
ascites
myasthenia gravis
evaluation of the transparency committee
nephrotic syndrome
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/jcms/c_1367679/spiroctazine
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12679_SPIROCTAZINE_RI_Avis1_CT12679.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400675
2013
France
French
spironolactone, althiazide drug combination
althiazide
drug combinations
spironolactone
sulfonamides
administration, oral
mineralocorticoid receptor antagonists
diuretics
antihypertensive agents
altizide and potassium-sparing agents
insurance, health, reimbursement
hypertension
edema
treatment outcome
tablets
diuretics, potassium sparing
evaluation of the transparency committee
benzothiadiazines

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62127360
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets
spironolactone, althiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61938189
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66032486
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62465928
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64640867
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64398047
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64347259
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60021127
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63478736
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67828415
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68016712
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62999896
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62038157
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68800618
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60337762
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69006984
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60058378
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64047906
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61315929
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64322708
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65687478
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64752670
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66404851
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63186956
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60259623
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60464076
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63603104
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63145849
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65154658
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63873854
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65696662
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64802027
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65618628
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64431166
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60625921
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61823226
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69360552
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60734372
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61662029
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69550295
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68916754
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68564751
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67907535
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone, althiazide drug combination
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65265313
2012
France
summary of product characteristics
package leaflet
spironolactone
spironolactone, althiazide drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65994267
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone, althiazide drug combination
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67504185
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone
spironolactone, althiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66043358
2012
France
summary of product characteristics
package leaflet
spironolactone, althiazide drug combination
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69594548
2012
France
summary of product characteristics
package leaflet
spironolactone
spironolactone, althiazide drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62673263
2012
France
summary of product characteristics
package leaflet
spironolactone
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62850272
2012
France
summary of product characteristics
package leaflet
spironolactone, althiazide drug combination
tablets
spironolactone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61457558
2012
France
summary of product characteristics
package leaflet
tablets
spironolactone

---
http://www.lecrat.eu/?s=Spironolactone
2011
France
drug information
spironolactone

---
http://www.cochrane.org/fr/CD000194
2011
false
true
false
France
United Kingdom
steroids
treatment outcome
review of literature
french abstract
spironolactone
placebos
acne vulgaris
hirsutism

---
http://www.has-sante.fr/portail/jcms/c_970617/spironolactone-microfine-ratiopharm
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/spironolactone_microfine_ratiopharm_-_ct-8535.pdf
2010
France
French
spironolactone
spironolactone
administration, oral
insurance, health, reimbursement
hyperaldosteronism
diuretics
mineralocorticoid receptor antagonists
hypertension
edema
myasthenia gravis
evaluation of the transparency committee
diuretics, potassium sparing

---
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=67623353&typedoc=R&ref=R0173112.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=67623353&typedoc=N&ref=N0173112.htm
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67623353
2010
France
French
hypertension
edema
drug interactions
pregnancy
breast feeding
tablets
spironolactone, althiazide drug combination
spironolactone, althiazide drug combination
drug combinations
administration, oral
althiazide
althiazide
spironolactone
spironolactone
sulfonamides
sulfonamides
diuretics
mineralocorticoid receptor antagonists
antihypertensive agents
altizide and potassium-sparing agents
benzothiadiazines
benzothiadiazines
benzothiadiazines
summary of product characteristics
package leaflet
diuretics, potassium sparing

---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Spironolactone-Hydrochlorothiazide.aspx
2010
false
Canada
French
English
buthiazide, spironolactone drug combination
child
hydrochlorothiazide
drug combinations
spironolactone
spironolactone
hydrochlorothiazide
diuretics
diuretics
hydrochlorothiazide and potassium-sparing agents
administration, oral
buthiazide, spironolactone drug combination
drug information
patient education handout
diuretics, potassium sparing

---
http://www.cochrane.org/fr/CD008169
2010
United Kingdom
France
French
meta-analysis
hypertension
spironolactone
diuretics
treatment outcome
french abstract

---
http://revmed.ch/RMS/2007/RMS-113/32315
2007
true
Switzerland
French
corticosteroid therapy
mineralocorticoid receptor antagonists
spironolactone
heart failure
receptors, mineralocorticoid
cardiovascular diseases
aldosterone
cardiovascular diseases
signal transduction
receptors, mineralocorticoid
eplerenone
journal article
drug information
diuretics, potassium sparing
Eplerenone

---
http://www.has-sante.fr/portail/display.jsp?id=c_614750
2007
France
French
capsules
administration, oral
spironolactone
furosemide
drug combinations
diuretics
mineralocorticoid receptor antagonists
furosemide and potassium-sparing agents
sodium potassium chloride symporter inhibitors
insurance, health, reimbursement
heart failure
Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule (clinical drug)
diuretics, potassium sparing
evaluation of the transparency committee

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2007.06163/
2007
false
Switzerland
French
spironolactone
mineralocorticoid receptor antagonists
diuretics, potassium sparing
journal article
Eplerenone

---
http://www.has-sante.fr/portail/display.jsp?id=c_400739
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032316.pdf
2005
France
French
hyperaldosteronism
hypertension
edema
myasthenia gravis
ascites
tablets
spironolactone
administration, oral
diuretics
mineralocorticoid receptor antagonists
insurance, health, reimbursement
treatment outcome
spironolactone
evaluation of the transparency committee
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/display.jsp?id=c_399659
2002
France
evaluation of the transparency committee
spironolactone
tablets

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.